Jury Finds in Favor of Pfizer in Zoloft Birth Defects Lawsuit

Philadelphia, PAThe family of a child born with birth defects they allege were caused by the antidepressant Zoloft, had their case defeated in court last week. The jury rejected the mother’s claims that Pfizer, the maker of Zoloft, hid the alleged health risks. The family of eight-year-old Mia Robinson sought at least $2.4 million in compensation for the child’s heart abnormalities.

Zoloft (sertraline) is used to treat depression, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder (PTSD) and premenstrual dysphoric disorder. However, some research has suggested serious Zoloft side effects, including an increased risk of heart defects. The link between Zoloft and heart defects has some people concerned that pregnant women should not take the medication. SSRIs such as Zoloft have also been linked to an increased risk of Persistent Pulmonary Hypertension of the Newborn.

Pfizer is currently facing over 1,000 Zoloft birth defect lawsuits. However, this ruling may dissuade Zoloft users from suing the pharmaceutical company. Notably, this is the second Zoloft lawsuit Pfizer has won in as many trials.

In the case heard in Philadelphia, the jury found the drug’s label adequate, as it carries a warning for physicians to weigh the benefits of using the medicine against its risks to pregnant women before prescribing it.